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Breast milk is the ideal diet for healthy infants and provides a balanced 
supply of nutrients for at least the first 4–6 months of life [1]. Most of the energy 
content of breast milk is contributed by milk fat, which contains fatty acids 
available from diet, from body stores and from endogenous synthesis [2]. Long-
chain fatty acids mainly originate from the diet, either directly or after interme-
diate incorporation into body stores. After their absorption, dietary long-chain 
fatty acids are reesterified in triacylglycerols in the intestinal mucosa and enter 
the circulation in the form of chylomicrons which are available for uptake by the 
mammary gland. In the fasting state, triacylglycerols are transported from the 
liver as very-low-density lipoproteins into the mammary gland. In several stud-
ies, it has been shown that human milk fatty acid composition is altered by dif-
ferent diets and by dietary supplementation with selected fatty acids [3, 4]. 
The finding that in lactating women the overall fat mobilization from adi-
pose tissue tends to exceed fat accretion supports the importance of body stores 
for milk fat synthesis [5]. Martin et al. [6] found a significant correlation between 
the linoleic acid (LA) content of white adipose tissue and the content of that fatty 
acid in colostrum and mature milk, demonstrating the contribution of maternal 
fat stores to human milk lipids. 
Endogenous synthesis must be considered as a source for milk fatty acids, 
except for the essential fatty acids. A considerable portion of the medium-chain 
fatty acids is synthesized in the mammary gland, and this is influenced by the 
carbohydrate content of the maternal diet [7]. While endogenous synthesis seems 
to be of minor quantitative importance for saturated and monounsaturated long-
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long-chain polyunsaturated derivatives of the essential fatty acids (LC-PUFA), 
namely arachidonic acid (AA) and docosahexaenoic acid (DHA). Vegetarians 
with marginal dietary intakes of LC-PUFA showed similar LC-PUFA content in 
breast milk compared to mothers consuming omnivorous diets [8]. Mobilization 
from body fat or another large endogenous pool of LC-PUFA, which may serve 
as a substrate source for milk production, might guarantee a more constant sup-
ply of LC-PUFA which appear to be of importance for infant development [9]. 
Quantitative determinations of dietary intake and milk output of a fatty 
acid cannot distinguish different sources from which milk fatty acids are derived. 
Rather, the application of stable isotope labeled analogues offers the possibility 
to elucidate the processes involved in the transfer of a fatty acid into milk either 
unchanged or as one of its conversion products. Since the use of stable isotope 
tracers in clinical investigations is safe and without adverse effects even in new-
born infants [10], they can be used to study the physiology of substrate flux in 
lactation. 
Hachey et al. [11] applied deuterated fatty acids to breast-feeding women 
and estimated from their results that only 29% of palmitic, oleic and linoleic 
acids incorporated into human milk fat within 72 h were derived from isotopi-
cally labeled dietary fatty acids during late lactation [11]. These findings suggest 
four major routes for the metabolism of dietary LA in lactating women: oxida-
tion, direct transfer into milk, incorporation into body stores and conversion 
into metabolites other than CO2. In an attempt to quantify these pathways, we 
studied the metabolic disposal of dietary LA in 6 healthy lactating women con-
suming omnivorous diets [12]. All women were breast-feeding one term infant 
and were studied repeatedly in the 2nd, 6th and 12th week of lactation. During 
each observation period, they continued their usual dietary habits. At the start of 
each study period, the women received 1 mg/kg body weight of uniformly 13C-
labeled LA as one bolus dose. 
Milk samples were obtained during 5 days, starting in the morning of the 
first study day before tracer application. A total of 15 samples was collected at 
time points 0, 6, 12, 24, 30, 36, 48, 54, 60, 72, 78, 84, 96, 102 and 108 h after the 
tracer intake. Daily milk production was determined by weighing the infant 
before and after feeding. Breath samples were collected by standard procedures 
before breakfast on the first study day, in hourly intervals until 12 h after start, 
and during the following 4 days at the same time points when milk was sampled. 
Since it was technically not feasible to perform measurements of total CO2 pro-
duction, a value of 300 mmol CO2/m² of body surface per hour was assumed. 
Quantitative analysis of milk samples was performed as described by Genzel-
Boroviczény et al. [13]. 13C content of fatty acid methyl esters and exhaled CO2 
was analyzed by gas chromatography combustion isotope ratio mass spectrome-
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We considered four exit routes for the tracer, namely milk LA, dihomo-γ-
linolenic acid and AA as well as breath CO2. In table 1, the corresponding recov-
eries for the first 24 h and for the whole observation period of 108 h are pre-
sented. It is obvious that a sizeable portion of the tracer (50–80%) was not recov-
ered with the applied approach. Several reasons need to be considered to explain 
this unrecovered tracer portion, e.g. incorporation of 13C into other components 
such as short- and medium-chain fatty acids which were not measured. Fur-
thermore considerable portions of lipid tracers catabolized in energy metabolism 
are not recovered in breath [14]. Even considering these possible metabolic 
routes for part of the tracer, it appears probable that a considerable portion of 
the tracer is also incorporated into large-body pools with slow turnover, resulting 
in a delayed appearance with low levels of enrichment in the sampled com-
pounds. 
The recovery determined after 5 days cannot be ascribed to direct transfer 
into milk or breath from the diet, as it has to be expected that the label recovered 
after several days was stored in pools with slow turnover and thus was not trans-
ferred directly from the diet. To choose any shorter time interval seems to be 
somewhat arbitrary and not well justifiable on the grounds of known physiology. 
For this reason, we have constructed a compartmental model, with 3 body pools 
for LA, including 1 pool with a slow turnover and no direct flux from this pool 
into milk or breath [12]. With this model, we calculated a direct transfer of 8.9 ± 
1.1% (mean ± SE) of the tracer into milk LA, if direct transfer is defined as the 
probability of dietary LA to be excreted into milk without entering the slow 
 
Table 1. Fractional recovery (mean ± SE) of orally applied 13C-LA in 6 lactating 
women 24 and 108 h after tracer intake in exhaled CO2 and milk LA, dihomo-γ-linolenic 
acid (DGLA) and AA, studied in the 2nd, 6th and 12th week of lactation 








CO2  24 10.7±2.4 10.7±1.8 10.2±1.7 
 108 14.8±2.6 23.9±3.7 15.9±3.5 
Milk LA  24 05.5±1.0 05.7±1.3 05.7±1.7 
 108 11.5±1.7 12.7±2.5 11.3±2.5 
Milk DGLA 24 0.06±0.02 0.05±0.01 0.05±0.01 
 108 0.20±0.05 0.20±0.04 0.17±0.04 
Milk AA 24 0.01±0.01   n.d.   n.d. 
 108 0.02±0.01 0.02±0.01 0.02±0.01 
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turnover pool. This result is well within the range defined by the cumulative 
recoveries after 12 and 108 h. 
With respect to the LC-PUFA derivatives, we conclude that the current die-
tary intake of LA is not the major precursor for milk dihomo-γ-linolenic acid and 
AA, since less than 0.3% of the LA tracer were recovered in its LC-PUFA me-
tabolites. However, this does not exclude dietary LA as a source for milk LC-
PUFA, because the LA incorporated into body stores may be a precursor for LC-
PUFA synthesis in maternal tissues. In this case, the body pools of dihomo-γ-
linolenic acid and AA might well be large enough to introduce a sufficient dilu-
tion of the 13C-enriched LC-PUFA synthesized from the LA tracer to make it 
undetectable with the methodology used in our study. In fact, the observed kinet-
ics of AA enrichment in milk, which did not reach a maximum 13C enrichment 
during the observation period of 5 days, appear to reflect a continued transfer of 
AA into milk synthesized from 13C-labeled LA in maternal tissues. 
There was no indication of a relationship between the transfer of labeled LA 
into milk and dietary LA intake (5–16 g/day). This is in agreement with the re-
ported immediate effect of dietary fatty acid intake on the fatty acid composition 
of milk [15] and opens the possibility to influence milk fat composition by ma-
ternal dietary supplementation.  
Therefore, we tested the effect of dietary supplementation with a DHA-rich 
oil (200 mg DHA/day) on the metabolic partitioning in lactating women. In this 
study two groups of 5 lactating women each consumed either the DHA-rich oil 
or a placebo oil without LC-PUFA for 2 weeks from the 4th week of lactation 
onwards. The supplementation resulted in a markedly different DHA content of 
the milk at the end of the supplementation period (0.37 vs. 0.21% w/w; p < 
0.001). On the 14th day of the intervention period, both groups ingested 2 mg/kg 
body weight of the same DHA-rich oil, but uniformly labeled with 13C. The re-
covery of 13CO2 in breath during 48 h after tracer intake was identical in both 
groups (15.4 vs. 15.6%; DHA-rich oil vs. placebo) [16]. Also, the cumulative 
recovery of DHA in milk was not significantly different between groups (9.1 vs. 
8.0%) [17]. Thus, an increased intake of DHA in lactating women does not 
down-regulate DHA transfer into milk and is an effective way to enhance milk 
DHA levels. 
Although maternal diet clearly affects the composition of human milk, these 
studies using stable isotope methodology show that only a minor proportion of 
dietary fatty acids is directly transferred into milk, whereas maternal body pools 
are the major contributors to milk fatty acids, including PUFA and LC-PUFA. 
Hence, short-term variations of dietary fat composition are buffered to some 
extent by intermediate incorporation into storage pools, and the PUFA and 
particularly LC-PUFA content in human milk as well as the supply to the breast-
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metabolic buffer benefits the breast-fed infant by reducing the variability in 
dietary supply of these essential substrates with great biological relevance for 
early human development. Part of the maternal dietary fatty acid intake, how-
ever, is directly transferred into milk, probably without significant influence of 
dietary intake in the tested ranges. This enables the possibility to influence milk 
fat composition by supplementing the diet of lactating mothers. 
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